We are recruiting participants (12 years and older) in a clinical trial for USH2A mediated Usher syndrome and Retinitis Pigmentosa. Check if you're eligible!
ProQR is recruiting people with Fuchs endothelial corneal dystrophy for a clinical study of an investigational RNA therapy. Learn more about the study and how to participate.
QR-504a is an investigational RNA therapy that aims slow down vision loss in people with TCF4 associated Fuchs endothelial corneal dystrophy (FECD). Learn more about the treatment and clinical trials.
Intravitreal injection is a common route of delivery of ocular medicine and used to treat a broad variety of conditions. It is a simple procedure that can be performed in-office by an ophthalmologist.
One of the most common issues in IRDs is the difficulty in diagnosis and clinical overlap. For IRD patients, having genetic testing can benefit them and their family.
Knowledge of inherited retinal disease (IRD) symptoms, genetic testing, available treatments and clinical trials is of paramount importance to help IRD patients in planning their life and find the support they need.
Inherited retinal diseases (IRDs) are a group of genetic ophthalmic diseases caused by rare mutations. They represent the leading cause of severe vision loss in persons between 15 and 45 years of age.
